Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition: results from the 1000 faces of lupus cohort.
Borowoy AM, Pope JE, Silverman E, Fortin PR, Pineau C, Smith CD, Arbillaga H, Gladman D, Urowitz M, Zummer M, Hudson M, Tucker L, Peschken C. Borowoy AM, et al. Among authors: arbillaga h. Semin Arthritis Rheum. 2012 Oct;42(2):179-85. doi: 10.1016/j.semarthrit.2012.03.011. Epub 2012 May 16. Semin Arthritis Rheum. 2012. PMID: 22595642
Influence of Education on Disease Activity and Damage in Systemic Lupus Erythematosus: Data From the 1000 Canadian Faces of Lupus.
George A, Wong-Pack A, Peschken CA, Silverman E, Pineau C, Smith CD, Arbillaga H, Zummer M, Bernatsky S, Hudson M, Hitchon C, Fortin PR, Nevskaya T, Pope JE; 1000 Canadian Faces of Lupus Investigators. George A, et al. Among authors: arbillaga h. Arthritis Care Res (Hoboken). 2017 Jan;69(1):124-132. doi: 10.1002/acr.22922. Epub 2016 Nov 21. Arthritis Care Res (Hoboken). 2017. PMID: 27110869 Free article.
Persistent Disease Activity Remains a Burden for Patients with Systemic Lupus Erythematosus.
Peschken CA, Wang Y, Abrahamowicz M, Pope J, Silverman E, Sayani A, Iczkovitz S, Ross J, Zummer M, Tucker L, Pineau C, Levy D, Hudson M, Hitchon CA, Huber AM, Smith CD, Avina-Zubieta A, Arbillaga H, Chédeville G, Wynant W, Fortin PR; CaNIOS 1000 Faces Investigators. Peschken CA, et al. Among authors: arbillaga h. J Rheumatol. 2019 Feb;46(2):166-175. doi: 10.3899/jrheum.171454. Epub 2018 Sep 15. J Rheumatol. 2019. PMID: 30219771
The 1000 Canadian faces of lupus: determinants of disease outcome in a large multiethnic cohort.
Peschken CA, Katz SJ, Silverman E, Pope JE, Fortin PR, Pineau C, Smith CD, Arbillaga HO, Gladman DD, Urowitz M, Zummer M, Clarke A, Bernatsky S, Hudson M; Canadian Network for Improved Outcomes in Systemic Lupus Erythematosus (CaNIOS). Peschken CA, et al. J Rheumatol. 2009 Jun;36(6):1200-8. doi: 10.3899/jrheum.080912. Epub 2009 Apr 15. J Rheumatol. 2009. PMID: 19369456
Clinical and serologic factors associated with lupus pleuritis.
Mittoo S, Gelber AC, Hitchon CA, Silverman ED, Pope JE, Fortin PR, Pineau C, Smith CD, Arbillaga H, Gladman DD, Urowitz MB, Zummer M, Clarke AE, Bernatsky S, Hudson M, Tucker LB, Petty RE; Canadian Network for Improved Outcomes in Systemic Lupus Erythematosus (CaNIOS); Peschken CA. Mittoo S, et al. Among authors: arbillaga h. J Rheumatol. 2010 Apr;37(4):747-53. doi: 10.3899/jrheum.090249. Epub 2010 Jan 28. J Rheumatol. 2010. PMID: 20110526
Association of smoking with cutaneous manifestations in systemic lupus erythematosus.
Bourré-Tessier J, Peschken CA, Bernatsky S, Joseph L, Clarke AE, Fortin PR, Hitchon C, Mittoo S, Smith CD, Zummer M, Pope J, Tucker L, Hudson M, Arbillaga H, Esdaile J, Silverman E, Chédeville G, Huber AM, Belisle P; Canadian Network for Improved Outcomes in Systemic Lupus Erythematosus 1000 Canadian Faces of Lupus Investigators; Pineau CA. Bourré-Tessier J, et al. Among authors: arbillaga h. Arthritis Care Res (Hoboken). 2013 Aug;65(8):1275-80. doi: 10.1002/acr.21966. Arthritis Care Res (Hoboken). 2013. PMID: 23401335 Free article.
A comparison between childhood and adult onset systemic lupus erythematosus adjusted for ethnicity from the 1000 Canadian Faces of Lupus Cohort.
Kim H, Levy DM, Silverman ED, Hitchon C, Bernatsky S, Pineau C, Smith CD, Tucker L, Petty R, Arbillaga H, Zummer M, Hudson M, Fortin P, Huber AM, Chedeville G, Peschken C, Pope JE. Kim H, et al. Among authors: arbillaga h. Rheumatology (Oxford). 2019 Feb 25:kez006. doi: 10.1093/rheumatology/kez006. Online ahead of print. Rheumatology (Oxford). 2019. PMID: 30805629
Medication use in systemic lupus erythematosus.
Bernatsky S, Peschken C, Fortin PR, Pineau CA, Urowitz MB, Gladman DD, Pope JE, Hudson M, Zummer M, Smith CD, Arbillaga HO, Clarke AE; Canadian Network for Improved Outcomes in Systemic Lupus Erythematosus (CaNIOS). Bernatsky S, et al. J Rheumatol. 2011 Feb;38(2):271-4. doi: 10.3899/jrheum.100414. Epub 2010 Nov 15. J Rheumatol. 2011. PMID: 21078722
Factors associated with time to diagnosis in early rheumatoid arthritis.
Barnabe C, Xiong J, Pope JE, Boire G, Hitchon C, Haraoui B, Carter Thorne J, Tin D, Keystone EC, Bykerk VP; Canadian early ArThritis CoHort Study Investigators. Barnabe C, et al. Rheumatol Int. 2014 Jan;34(1):85-92. doi: 10.1007/s00296-013-2846-5. Epub 2013 Aug 30. Rheumatol Int. 2014. PMID: 23989941
20 results